MedTrace Logo

Night Driving After Trifocal Versus Monofocal IOL Implantation

NCT07755189 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-08-10

No results posted yet for this study

Summary

This prospective observational cohort study will compare night-driving visual difficulty and visual disturbances after bilateral implantation of an Alcon trifocal intraocular lens or an Alcon monofocal intraocular lens in adults undergoing cataract surgery. The type of intraocular lens will be selected by each participant and the treating ophthalmologist as part of routine clinical care, and will not be assigned by the investigators.

Eligible participants must have a valid motor vehicle driving license and a stable history of night driving during the previous 3 months. The primary outcome will be the total score of the Visual Function and Night Driving Questionnaire (VND-Q) at 3 months postoperatively. Secondary assessments will include glare adaptation, self-rated night-driving quality and driving speed, changes in night-driving behavior, visual disturbances, distance, intermediate and near visual acuity, contrast sensitivity, whole-eye aberrations, pupil diameter, defocus performance, reading speed, spectacle independence, and participant satisfaction.

Conditions

  • Cataract
  • Presbyopia Correction

Interventions

DEVICE

AcrySof IQ PanOptix TFNT00 Trifocal Intraocular Lens

AcrySof IQ PanOptix TFNT00 Trifocal Intraocular Lens

DEVICE

Alcon Monofocal Intraocular Lens

Alcon Monofocal Intraocular Lens

Sponsors & Collaborators

  • Jin Yang

    lead OTHER

Principal Investigators

  • Jin Yang · Fudan University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-30
Primary Completion
2031-08-30
Completion
2031-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07755189 on ClinicalTrials.gov